Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Category C: Demonstration Projects to Implement and Evaluate Innovative, High-Impact HIV Prevention Interventions and Strategies

In March 2012, CDC awarded 30 health departments competitive Category C funding from Funding Opportunity Announcement (FOA) PS12-1201: Comprehensive Human Immunodeficiency Virus (HIV) Prevention Programs for Health Departments to implement, conduct, and evaluate innovative high-impact prevention (HIP) non-research projects that were consistent with the National HIV/AIDS Strategy.  Projects from Category C were funded for a total of approximately $65 million for four years through December 2015.  Health departments were required to conduct project activities in at least one of five Focus Areas: HIV testing, Linkage and Re-engagement to Care for HIV-infected Persons, Use of HIV Surveillance Data, Interventions, and Use of Advanced Technology.  Main outcomes desired from Category C projects included documented successful high-impact activities and successful innovative practices transferred to routine public health practice after Category C funding ended.

The CDC Division of HIV/AIDS Prevention (DHAP) assigned Technical Monitors from five DHAP Branches and the Office of the Division Director to support the projects as needed with subject matter expertise.  Locally, 19 universities were involved with Category C projects: three in a lead role and six conducting at least two types of activities (e.g., testing, clinical services, and evaluation).  Community based organizations (CBOs) were involved with 21 Category C projects: seven in a lead role, nine who conducted more than one activity, and five who conducted one activity.  This Overview is based on information from health department applications, progress reports, conference calls, emails, site visit reports, and comprehensive final reports and is intended primarily for PS12-1201 grantees and HIV prevention policy and decision makers at the national and local levels.

Summaries

Full Report

Overview
Focus Area: HIV Testing
Focus Area: Linkage and Re-engagement to HIV Care
Focus Area: Use of HIV Surveillance Data
Focus Area: Interventions
Focus Area: Use of Advanced Technology
Acknowledgments

TOP